Decreased plasma adiponectin concentration in patients with essential hypertension

American Journal of Hypertension

Volumn 16, Issue 1, 2003, Pages 72-75

  Adamczak, Marcin ^a   Wiȩcek, Andrzej ^a   Funahashi, Tohru ^b   Chudek, Jerzy ^a   Kokot, Franciszek ^a   Matsuzawa, Yuji ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Adipose tissue; Essential hypertension; Leptin

Indexed keywords

ADIPONECTIN; LEPTIN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; PROTEINS;

EID: 0037230545     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03197-7     Document Type: Article

References (15)

1. Kannel WB, Brand M, Skinner JJ Jr, Dawber TR, McNamara PM: The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 1967;67:48-59.
2. Wiȩcek A, Kokot F, Chudek J, Adamczak M: The adipose tissue - A novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002;17:191-195.
3. Maeda K, Okubo K, Shimoura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286-289.
4. Arita Y, Kihara S, Ouchi N, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
5. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamota Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppress lipid accumulation and class A receptor expression in human monocytederived macrophages. Circulation 2001;103:1057-1063.
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobr K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 2001;7:941-946.
7. Okamoto Y, Arita Y, Nishida M, Maraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y: An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50.
8. Ouchi N, Kihara S, Arita Y Maeda K. Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
9. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita Y, Kamon J, Satoh H, Yano W, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863-25866.
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
11. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
12. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin in essential hypertension. J Nephrol 2002;15:507-511.
13. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001;507:142-146.
14. Esler M: The sympathetic system and hypertension. Am J Hypertens 2000;13(Suppl 2):99S-105S.
15. Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 1999;17:719-734.